Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNNN.L Regulatory News (NNN)

  • There is currently no data for NNN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Strategic Update

4 Jul 2022 07:00

RNS Number : 0994R
Nanosynth Group PLC
04 July 2022
 

 

4 July 2022 

nanosynth group plc

("nanosynth", the "Company" or the "Group")

Further Strategic Update

nanosynth, the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, announces a strategic update further to its notification of 1 June 2022.

The business is now ten months into its turnaround strategy following the appointment of Mark Duffin as CEO in September 2021, and whilst the Company understands and appreciates shareholders' frustration at the speed of progress and irregular newsflow, the Group would like to emphasise that good momentum is being gained and updates are being provided to shareholders when appropriate to do so and in accordance with the Company's regulatory obligations.

The Company's new management team members are all highly successful in their respective fields of expertise and are working well together. They are both committed and motivated to realise the significant potential value inherent in the Company's technological development programme and, if successful, the Board remains confident that this will create substantial shareholder value in the near term. The Company is continuing to strengthen its team and expertise as demonstrated by the recent appointments of Peter Gray and Andrew Stedman to the board.

As announced on 1 June 2022, due to a shift in the market with regard to mask mandates, a decision was taken not to remain in face mask production and supply. However, the partnership established with Volz Holdings v.o.s ("Volz") remains of great value to the Company and its plan is to take the technology developed with Volz and use it to spray directly onto the media for masks and many other products within the HVAC market and beyond.

Whilst the partnership with Volz is still in its early stages, trials have been run to help both companies develop a standard retro fit to media production lines for future clients so that installation and execution become streamlined. The Company has successfully proven the technology and has had exciting results on the media tested at Volz to date. A fifth trial production run is due to take place in the coming weeks and the Board is now confident to apply for REACH UK registration (UK Registration, Evaluation, Authorisation and restriction of Chemicals) with the HSE which will allow the Company to produce up to 60 tonnes of copper (ii) oxide nano material per year. The Company has already been granted the ability to produce more copper (ii) oxide nano material than is forecast to be required for the targeted HVAC market under a PPORD licence (Production and Process Orientated Research and Development) and the final environmental fate report will be created after the forthcoming trial which will allow the REACH UK registration to be progressed. This will then open the market for the Company, allowing Volz to apply the technology to all of its products which is expected to lead to wider industry adoption of the technology. Expressions of interest are already coming from the market and an exciting pipeline is being established.

Also announced on 1 June 2022 was the Company's R&D roadmap across seven verticals. Each of the projects in the map are based on a fully considered business case, market analysis and detailed work schedules. The Company has grouped the required patents into 11 distinct categories and is currently in the process of applying for them.

As the initial phases of the works schedule are completed, the Company will seek to enter into long term commercial agreements with appropriate partners. Discussions are at various stages of progress with credible market counterparties and the Directors expect that commercial partnerships, once agreed, will commence with an R&D partnership, paid for by the partner, to deliver the project and then move to an exclusive commercial agreement based on minimum volume requirements. Although the Directors are confident that these discussions will lead to binding agreements, there can be no certainty in this regard and further updates will be announced once agreements are finalised.

During the turnaround of the business a key focus has been to move P2F from an R&D business established with a university to a commercial standalone company. The Company has taken the patent for a one disk nano producing reactor to a 4-disk reactor that produces the same quality and consistency. The Company is now in the process of building two full scale production reactors containing 20 disks. This will provide the potential to be the largest nano producer in the marketplace. GB Nano Ltd has been established as a wholly owned subsidiary of the Group and will act as the vehicle to sell nano ingredients directly to customers. This is being set up as an e-commerce business and will initially launch with 40 plus products. The site is currently being developed and the ingredients produced for future launch.

M&A remains a longer-term strategy for the Company but the current market climate does not support the Company's aspirations. Rather than lose time, the board has worked at some length to identify suitable targets and is looking to establish joint ventures with a right to buy when the market permits.

Mark Duffin, Chief Executive of nanosynth, commented: "Rapid progress is being made and we look forward to updating shareholders as our various initiatives build traction. The team has gone above and beyond for the business and the current progress is testament to the strategy and their commitment. I sincerely thank them for their continued support and effort and would like to also thank our shareholders for their patience and support as we transform the business. We look forward to providing further updates as we progress our strategy."

 

 

 

ENQUIRIES :

nanosynth group plc

Mark Duffin (Chief Executive Officer) 

 

via IFC Advisory

SP Angel Corporate Finance LLP 

Nominated Adviser and Broker

Stuart Gledhill

Caroline Rowe

   

+44 20 3470 0470

 

 

IFC Advisory Ltd  

Graham Herring

Zach Cohen

+44 20 3934 6630

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSLFIFEESELW
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Nanosynth Group PLC
14th Nov 20234:10 pmRNSCompany Insolvency
29th Sep 20237:00 amRNSAccounts Update
30th Aug 20233:30 pmRNSAppointment of Joint Broker
30th Aug 20237:00 amRNSResignation of Finance Director
28th Jul 20233:53 pmRNSResignation of Chief Executive Officer
26th Jun 202311:24 amRNSAccounts Update
14th Jun 20233:27 pmRNSNotice re. General Meeting
24th May 20232:27 pmRNSNotice of General Meeting
16th May 202312:28 pmRNSProposal to Appoint Liquidators
16th May 202312:03 pmRNSSuspension - Nanosynth Group plc
28th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20233:05 pmRNSFinancial Position
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20233:42 pmRNSDirectorate Change
20th Jan 202310:48 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSCorporate and Commercial Update
10th Jan 20237:00 amRNSPlacing and Subscription to raise £0.4 million
4th Jan 20232:56 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Report
6th Sep 20224:47 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20222:05 pmRNSSecond Price Monitoring Extn
31st Aug 20222:00 pmRNSPrice Monitoring Extension
31st Aug 202211:05 amRNSSecond Price Monitoring Extn
31st Aug 202211:00 amRNSPrice Monitoring Extension
31st Aug 20229:05 amRNSSecond Price Monitoring Extn
31st Aug 20229:00 amRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSSuccessful Trial Results
30th Aug 20227:00 amRNSJoint Development Agreement in Cosmetics Market
26th Aug 20227:00 amRNSLanstead Subscription and Sharing Agreement
1st Aug 20222:05 pmRNSSecond Price Monitoring Extn
1st Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20221:08 pmRNSPDMR Dealings
26th Jul 20222:41 pmRNSResult of AGM
12th Jul 202211:06 amRNSSecond Price Monitoring Extn
12th Jul 202211:00 amRNSPrice Monitoring Extension
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
11th Jul 20224:40 pmRNSSecond Price Monitoring Extn
11th Jul 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
11th Jul 202210:30 amRNSDirector/PDMR dealings
6th Jul 20229:00 amRNSPrice Monitoring Extension
5th Jul 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.